Chemed ROE 2012-2026 | CHE
Current and historical return on equity (ROE) values for Chemed (CHE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Chemed ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $0.26B | $1.03B | 25.26% |
| 2025-12-31 | $0.27B | $1.11B | 23.90% |
| 2025-09-30 | $0.28B | $1.14B | 24.30% |
| 2025-06-30 | $0.29B | $1.18B | 24.50% |
| 2025-03-31 | $0.31B | $1.19B | 26.05% |
| 2024-12-31 | $0.30B | $1.19B | 25.46% |
| 2024-09-30 | $0.30B | $1.18B | 25.52% |
| 2024-06-30 | $0.30B | $1.13B | 26.65% |
| 2024-03-31 | $0.28B | $1.07B | 26.56% |
| 2023-12-31 | $0.27B | $0.99B | 27.48% |
| 2023-09-30 | $0.24B | $0.91B | 26.74% |
| 2023-06-30 | $0.23B | $0.84B | 26.97% |
| 2023-03-31 | $0.24B | $0.77B | 30.99% |
| 2022-12-31 | $0.25B | $0.72B | 34.68% |
| 2022-09-30 | $0.26B | $0.67B | 38.87% |
| 2022-06-30 | $0.28B | $0.69B | 40.22% |
| 2022-03-31 | $0.27B | $0.74B | 36.45% |
| 2021-12-31 | $0.27B | $0.80B | 33.59% |
| 2021-09-30 | $0.31B | $0.87B | 35.39% |
| 2021-06-30 | $0.30B | $0.88B | 34.72% |
| 2021-03-31 | $0.33B | $0.85B | 38.91% |
| 2020-12-31 | $0.32B | $0.78B | 40.80% |
| 2020-09-30 | $0.27B | $0.74B | 36.72% |
| 2020-06-30 | $0.26B | $0.71B | 37.12% |
| 2020-03-31 | $0.23B | $0.68B | 34.34% |
| 2019-12-31 | $0.22B | $0.65B | 33.92% |
| 2019-09-30 | $0.21B | $0.62B | 33.85% |
| 2019-06-30 | $0.20B | $0.59B | 33.98% |
| 2019-03-31 | $0.21B | $0.58B | 35.61% |
| 2018-12-31 | $0.21B | $0.56B | 36.90% |
| 2018-09-30 | $0.21B | $0.54B | 37.95% |
| 2018-06-30 | $0.19B | $0.52B | 36.52% |
| 2018-03-31 | $0.11B | $0.50B | 22.85% |
| 2017-12-31 | $0.10B | $0.49B | 19.88% |
| 2017-09-30 | $0.08B | $0.49B | 15.34% |
| 2017-06-30 | $0.07B | $0.49B | 13.64% |
| 2017-03-31 | $0.11B | $0.49B | 23.10% |
| 2016-12-31 | $0.11B | $0.49B | 22.27% |
| 2016-09-30 | $0.11B | $0.49B | 21.98% |
| 2016-06-30 | $0.11B | $0.49B | 22.37% |
| 2016-03-31 | $0.11B | $0.49B | 22.60% |
| 2015-12-31 | $0.11B | $0.49B | 22.69% |
| 2015-09-30 | $0.11B | $0.47B | 23.43% |
| 2015-06-30 | $0.11B | $0.46B | 23.29% |
| 2015-03-31 | $0.10B | $0.45B | 23.06% |
| 2014-12-31 | $0.10B | $0.44B | 22.56% |
| 2014-09-30 | $0.09B | $0.44B | 21.01% |
| 2014-06-30 | $0.09B | $0.44B | 19.25% |
| 2014-03-31 | $0.08B | $0.45B | 16.86% |
| 2013-12-31 | $0.08B | $0.46B | 16.74% |
| 2013-09-30 | $0.08B | $0.46B | 17.57% |
| 2013-06-30 | $0.09B | $0.47B | 17.97% |
| 2013-03-31 | $0.09B | $0.47B | 19.59% |
| 2012-12-31 | $0.09B | $0.45B | 19.68% |
| 2012-09-30 | $0.09B | $0.44B | 19.89% |
| 2012-06-30 | $0.09B | $0.43B | 20.69% |
| 2012-03-31 | $0.09B | $0.44B | 19.97% |
| 2011-12-31 | $0.09B | $0.45B | 19.19% |
| 2011-09-30 | $0.08B | $0.46B | 18.03% |
| 2011-06-30 | $0.08B | $0.49B | 16.83% |
| 2011-03-31 | $0.08B | $0.49B | 16.42% |
| 2010-12-31 | $0.08B | $0.50B | 16.34% |
| 2010-09-30 | $0.08B | $0.51B | 15.23% |
| 2010-06-30 | $0.08B | $0.49B | 15.42% |
| 2010-03-31 | $0.07B | $0.47B | 15.62% |
| 2009-12-31 | $0.07B | $0.45B | 16.33% |
| 2009-09-30 | $0.07B | $0.43B | 17.10% |
| 2009-06-30 | $0.07B | $0.40B | 17.73% |
| 2009-03-31 | $0.07B | $0.38B | 18.42% |
| 2008-12-31 | $0.07B | $0.37B | 18.24% |
| 2008-09-30 | $0.07B | $0.36B | 18.66% |
| 2008-06-30 | $0.07B | $0.36B | 19.03% |
| 2008-03-31 | $0.06B | $0.35B | 17.44% |
| 2007-12-31 | $0.06B | $0.36B | 16.84% |
| 2007-09-30 | $0.06B | $0.38B | 16.20% |
| 2007-06-30 | $0.05B | $0.39B | 12.94% |
| 2007-03-31 | $0.06B | $0.42B | 13.22% |
| 2006-12-31 | $0.05B | $0.41B | 12.39% |
| 2006-09-30 | $0.04B | $0.40B | 9.19% |
| 2006-06-30 | $0.04B | $0.39B | 11.20% |
| 2006-03-31 | $0.04B | $0.38B | 10.54% |
| 2005-12-31 | $0.04B | $0.37B | 9.83% |
| 2005-09-30 | $0.05B | $0.35B | 13.59% |
| 2005-06-30 | $0.04B | $0.34B | 13.02% |
| 2005-03-31 | $0.04B | $0.33B | 13.25% |
| 2004-12-31 | $0.03B | $0.31B | 9.04% |
| 2004-09-30 | $0.00B | $0.28B | -0.36% |
| 2004-06-30 | $-0.01B | $0.25B | -3.64% |
| 2004-03-31 | $-0.01B | $0.22B | -6.29% |
| 2003-12-31 | $0.00B | $0.20B | -1.49% |
| 2003-09-30 | $-0.01B | $0.21B | -4.35% |
| 2003-06-30 | $-0.01B | $0.21B | -2.37% |
| 2003-03-31 | $0.00B | $0.21B | -1.41% |
| 2002-12-31 | $0.00B | $0.22B | -0.93% |
| 2002-09-30 | $0.00B | $0.22B | -0.46% |
| 2002-06-30 | $-0.01B | $0.22B | -3.69% |
| 2002-03-31 | $-0.01B | $0.22B | -5.52% |
| 2001-12-31 | $-0.01B | $0.22B | -5.48% |
| 2001-09-30 | $0.01B | $0.22B | 4.99% |
| 2001-06-30 | $0.02B | $0.22B | 7.35% |
| 2001-03-31 | $0.02B | $0.22B | 9.63% |
| 2000-12-31 | $0.02B | $0.22B | 9.67% |
| 2000-09-30 | $0.02B | $0.21B | 9.85% |
| 2000-06-30 | $0.02B | $0.22B | 9.30% |
| 2000-03-31 | $0.02B | $0.21B | 8.87% |
| 1999-12-31 | $0.02B | $0.22B | 8.86% |
| 1999-09-30 | $0.02B | $0.22B | 7.83% |
| 1999-06-30 | $0.02B | $0.22B | 8.20% |
| 1999-03-31 | $0.02B | $0.22B | 8.59% |
| 1998-12-31 | $0.02B | $0.23B | 8.90% |
| 1998-09-30 | $0.02B | $0.23B | 9.29% |
| 1998-06-30 | $0.03B | $0.23B | 12.35% |
| 1998-03-31 | $0.03B | $0.23B | 12.40% |
| 1997-12-31 | $0.03B | $0.22B | 13.54% |
| 1997-09-30 | $0.04B | $0.22B | 16.44% |
| 1997-06-30 | $0.03B | $0.22B | 12.98% |
| 1997-03-31 | $0.03B | $0.21B | 13.08% |
| 1996-12-31 | $0.03B | $0.21B | 14.95% |
| 1996-09-30 | $0.03B | $0.21B | 12.28% |
| 1996-06-30 | $0.03B | $0.21B | 14.32% |
| 1996-03-31 | $0.03B | $0.21B | 14.13% |
| 1995-12-31 | $0.02B | $0.20B | 11.50% |
| 1995-09-30 | $0.04B | $0.19B | 22.65% |
| 1995-06-30 | $0.04B | $0.18B | 22.68% |
| 1995-03-31 | $0.04B | $0.17B | 25.88% |
| 1994-12-31 | $0.04B | $0.16B | 27.54% |
| 1994-09-30 | $0.02B | $0.15B | 15.59% |
| 1994-06-30 | $0.02B | $0.14B | 15.25% |
| 1994-03-31 | $0.02B | $0.14B | 14.21% |
| 1993-12-31 | $0.02B | $0.14B | 14.60% |
| 1993-09-30 | $0.02B | $0.14B | 13.94% |
| 1993-06-30 | $0.02B | $0.14B | 14.79% |
| 1993-03-31 | $0.02B | $0.14B | 13.36% |
| 1992-12-31 | $0.02B | $0.14B | 11.13% |
| 1992-09-30 | $0.02B | $0.14B | 11.76% |
| 1992-06-30 | $0.02B | $0.14B | 10.93% |
| 1992-03-31 | $0.06B | $0.14B | 40.29% |
| 1991-12-31 | $0.05B | $0.13B | 40.38% |
| 1991-09-30 | $0.05B | $0.13B | 40.88% |
| 1991-06-30 | $0.05B | $0.12B | 43.79% |
| 1991-03-31 | $0.01B | $0.11B | 10.60% |
| 1990-12-31 | $0.02B | $0.12B | 13.33% |
| 1990-09-30 | $0.02B | $0.12B | 16.39% |
| 1990-06-30 | $0.02B | $0.12B | 18.70% |
| 1990-03-31 | $0.03B | $0.12B | 20.41% |
| 1989-12-31 | $0.03B | $0.12B | 21.49% |
| 1989-09-30 | $0.03B | $0.12B | 21.10% |
| 1989-06-30 | $0.02B | $0.12B | 20.34% |
| 1989-03-31 | $0.02B | $0.12B | 19.41% |
| 1988-12-31 | $0.02B | $0.12B | 20.30% |
| 1988-09-30 | $0.02B | $0.12B | 20.21% |
| 1988-06-30 | $0.02B | $0.12B | 19.13% |
| 1988-03-31 | $0.02B | $0.12B | 18.26% |
| 1987-12-31 | $0.02B | $0.12B | 16.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |